Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ermidrà
- Development stage
- Unknown
- Lead developer
- Nextmune
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Ermidrà is a topical skin rehydration spray developed by Nextmune for use in dogs and cats. It is designed to address skin dehydration caused by environmental factors such as summer heat, indoor heating, or post-shampooing, and is also suitable for skin prone to seborrhea, crusts, or scaling. The formulation contains moisturizing agents including propylene glycol, D-panthenol, and glycerin to restore the skin barrier and maintain hydration. Additionally, it incorporates epilobium extract and zinc gluconate, which help regulate sebum production and provide a soothing, cooling effect to manage symptomatic dermal inflammation and irritation.
- Brand names
- Ermidrà
Beyond the preview
Go deeper on Ermidrà.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ermidrà.